BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16691038)

  • 1. Thiopurine S-methyltransferase pharmacogenetics: genotype to phenotype correlation in the Slovenian population.
    Milek M; Murn J; Jaksic Z; Lukac Bajalo J; Jazbec J; Mlinaric Rascan I
    Pharmacology; 2006; 77(3):105-14. PubMed ID: 16691038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiopurine S-Methyltransferase as a Pharmacogenetic Biomarker: Significance of Testing and Review of Major Methods.
    Asadov C; Aliyeva G; Mustafayeva K
    Cardiovasc Hematol Agents Med Chem; 2017 Nov; 15(1):23-30. PubMed ID: 28552060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human thiopurine S-methyltransferase pharmacogenetics: variant allozyme misfolding and aggresome formation.
    Wang L; Nguyen TV; McLaughlin RW; Sikkink LA; Ramirez-Alvarado M; Weinshilboum RM
    Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9394-9. PubMed ID: 15967990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four human thiopurine s-methyltransferase alleles severely affect protein structure and dynamics.
    Rutherford K; Daggett V
    J Mol Biol; 2008 Jun; 379(4):803-14. PubMed ID: 18482735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of Thiopurine S-Methyltransferase (TPMT) Activity in Human Erythrocytes by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
    Li L; Atkinson N; Crews KR; Molinelli AR
    Methods Mol Biol; 2024; 2737():465-472. PubMed ID: 38036847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiopurine S-methyltransferase pharmacogenetics: autophagy as a mechanism for variant allozyme degradation.
    Li F; Wang L; Burgess RJ; Weinshilboum RM
    Pharmacogenet Genomics; 2008 Dec; 18(12):1083-94. PubMed ID: 18820593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiopurine S-methyltransferase testing for averting drug toxicity: a meta-analysis of diagnostic test accuracy.
    Zur RM; Roy LM; Ito S; Beyene J; Carew C; Ungar WJ
    Pharmacogenomics J; 2016 Aug; 16(4):305-11. PubMed ID: 27217052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-Specific Distribution of
    Gallardo-Cóndor J; Naranjo P; Atarihuana S; Coello D; Guevara-Ramírez P; Flores-Espinoza R; Burgos G; López-Cortés A; Cabrera-Andrade A
    Ther Clin Risk Manag; 2023; 19():1005-1018. PubMed ID: 38050617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome analysis reveals involvement of thiopurine S-methyltransferase in oxidation-reduction processes.
    Šmid A; Štajdohar M; Milek M; Urbančič D; Karas Kuželički N; Tamm R; Metspalu A; Mlinarič-Raščan I
    Eur J Pharm Sci; 2024 Jan; 192():106616. PubMed ID: 37865284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-Wide Association Study for the Genetic Determinants of Thiopurine Methyltransferase Protein Expression in Human Livers and Racial Differences.
    Smith LS; Wang X; Shi J; He B; Zhu HJ
    Pharm Res; 2023 Nov; 40(11):2525-2531. PubMed ID: 37430149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molybdenum Cofactor Catabolism Unravels the Physiological Role of the Drug Metabolizing Enzyme Thiopurine S-Methyltransferase.
    Pristup J; Schaeffeler E; Arjune S; Hofmann U; Angel Santamaria-Araujo J; Leuthold P; Friedrich N; Nauck M; Mayr S; Haag M; Muerdter T; Marner FJ; Relling MV; Evans WE; Schwarz G; Schwab M
    Clin Pharmacol Ther; 2022 Oct; 112(4):808-816. PubMed ID: 35538648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiopurine S-methyltransferase testing for averting drug toxicity in patients receiving thiopurines: a systematic review.
    Roy LM; Zur RM; Uleryk E; Carew C; Ito S; Ungar WJ
    Pharmacogenomics; 2016 Apr; 17(6):633-56. PubMed ID: 27020704
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Perini JA; Basta PC; Suarez-Kurtz G
    Front Pharmacol; 2024; 15():1359570. PubMed ID: 38379902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential molecular mechanisms of substrate recognition by selenium methyltransferases, INMT and TPMT, in selenium detoxification and excretion.
    Fukumoto Y; Kyono R; Shibukawa Y; Tanaka YK; Suzuki N; Ogra Y
    J Biol Chem; 2024 Feb; 300(2):105599. PubMed ID: 38159853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Reference Materials for TPMT and NUDT15: A GeT-RM Collaborative Project.
    Pratt VM; Wang WY; Boone EC; Broeckel U; Cody N; Edelmann L; Gaedigk A; Lynnes TC; Medeiros EB; Moyer AM; Mitchell MW; Scott SA; Starostik P; Turner A; Kalman LV
    J Mol Diagn; 2022 Oct; 24(10):1079-1088. PubMed ID: 35931342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset.
    Langer T; Clemens E; Broer L; Maier L; Uitterlinden AG; de Vries ACH; van Grotel M; Pluijm SFM; Binder H; Mayer B; von dem Knesebeck A; Byrne J; van Dulmen-den Broeder E; Crocco M; Grabow D; Kaatsch P; Kaiser M; Spix C; Kenborg L; Winther JF; Rechnitzer C; Hasle H; Kepak T; van der Kooi AF; Kremer LC; Kruseova J; Bielack S; Sorg B; Hecker-Nolting S; Kuehni CE; Ansari M; Kompis M; van der Pal HJ; Parfitt R; Deuster D; Matulat P; Tillmanns A; Tissing WJE; Beck JD; Elsner S; Am Zehnhoff-Dinnesen A; van den Heuvel-Eibrink MM; Zolk O;
    Data Brief; 2020 Oct; 32():106227. PubMed ID: 32939381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel thiopurine S-methyltransferase (
    Lee CK; Huan PT; Chai CN; Ng LJ; Koay ES; Lee OF; Tan M; Loh TP
    Clin Chem Lab Med; 2024 Apr; ():. PubMed ID: 38661453
    [No Abstract]   [Full Text] [Related]  

  • 18. Cisplatin-induced ototoxicity and the role of pharmacogenetic testing.
    Wyatt LE; Kennedy MJ
    J Pediatr Pharmacol Ther; 2012 Oct; 17(4):395-9. PubMed ID: 23411597
    [No Abstract]   [Full Text] [Related]  

  • 19. Polymorphic variation in TPMT is the principal determinant of TPMT phenotype: A meta-analysis of three genome-wide association studies.
    Tamm R; Mägi R; Tremmel R; Winter S; Mihailov E; Smid A; Möricke A; Klein K; Schrappe M; Stanulla M; Houlston R; Weinshilboum R; Mlinarič Raščan I; Metspalu A; Milani L; Schwab M; Schaeffeler E
    Clin Pharmacol Ther; 2017 May; 101(5):684-695. PubMed ID: 27770449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use.
    Mlakar V; Huezo-Diaz Curtis P; Satyanarayana Uppugunduri CR; Krajinovic M; Ansari M
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.